Raloxifene

( Evista )

Medically Reviewed by Dr. Harshi Dhingra, M.D.

Last Reviewed: Mar 24, 2025

Drug Details


Common Brands:

Evista

Availability:

Prescription only

Therapeutic Class:

Selective estrogen receptor modulators

Forms:

Tablet

Administration:

By mouth

Therapeutic Uses:

  • To prevent and treat osteoporosis in postmenopausal women with osteoporosis
  • To lower the risk of invasive breast cancer in postmenopausal women at high risk

Controlled Status:

Not a controlled substance


Raloxifene (Evista) Drug Class

Raloxifene (ral-ox-eh-feen) is a selective estrogen receptor modulator (SERM).

Raloxifene (Evista) Age Range

Raloxifene is approved for use in postmenopausal women. This drug is not indicated in premenopausal women or in men. The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age.